EXHIBIT F Seventeen-year survival experience (by percent) with 453 hypertensive patients [ Adapted from data of Robert Sterling Palmer, M.D., reported in Journal of Chronic Diseases, December 1959 (cases collected 1935-41 with percentage survival yearly from 1941 to 1958)] 1942 (1 year) 1945 (5 years) 1950 (10 years) 1955 (15 years) 1957 (17 years) 1 The clinical syndrome of malignant hypertension. 2 Hypertension with organic changes in head, heart, or kidneys plus functional failure in one of these areas. 3 Hypertension with organic changes in head, heart, or kidney but with no functional failure in these areas. 4 Hypertension with no recognized organic changes or functional failure. EXHIBIT G Expectation of life and mortality rate at selected ages among diabetics and among white persons in the general population [Experience in 1947-51 for diabetic patients in Joslin Clinic first observed in 1930-51 and for general population of United States in 1949-51] 1 Excludes deaths within 1 week of first observation or hospital discharge. EXHIBIT H Longevity compensation based on age at inception and attained age Attained age 30 (standard future expectancy, bility Age at inception of disability EXHIBIT H-Continued Longevity compensation based on age at inception and attained age—Continued Age at inception age of disa Reduc Reduc Reduc evaluation bility tion in Remain life ex ing span Total Annual Monthly due 1 rate tion in Remain rate life ex ing span pectancy pectancy life expectancy ing span due 1 1 Based on $2,700 per year (100 percent equals $225 per month times 12). EXHIBIT I SURVIVORSHIP RATES (PERCENT) COMPARISON: HEART VERSUS CANCER [Certain cancers wherein the mortality is greatly in excess of category I heart disease above, i.e., where average life expectancy is extremely short, amounting to only months or 2 to 3 years] [Cancers in which mortality is considerably in excess of category I of heart disease above] 30 [Cancers in which mortality approximates categories I and II of heart disease above] ? Where cancer group consisted of less than 200 cases studied, survival rates were not computed. 3 Not observed for full 15 years. 4 Less than 200 cases studied at 15-year level. EXHIBIT I-Continued Malignant neoplasms-Continued GROUP IV [Cancers in which mortality is more favorable or approximates that in category III of heart disease above] Association of Life Insurance Medical Directors of America. Beard, O. W., Hipp, H. R., Robins, Benford, D. M. Biorck, G.. Bolt, W. and Lew, E. A Connecticut State Department of Health (Griswold, M. H., Wilder, C. S., Cutler, S. J., Pollack, E. S.) Dublin, L. I. and Lotka, A. J. Dublin, L. I. and Lotka, A. J. Dunstan, H. P. et al. Entmacher, P. S. Fitzpatrick, M. J. Graphic Chart Service Prognostic Value of Life Insurance Mortality Investigations, October 1955. Initial Myocardial Infarction Among 503 Veterans D. M. & S., VA, June 1960. 1,000 Hypertensive Patients Followed from 16 to 22 Years Acta Medica Scandinavica Supplement 312, 1956, pp 175-184. Review of the Build and Blood Pressure Study 1959. Proceedings of 48th Annual Meeting of Medical Section of American Life Convention, 1960. Studies on Myocardial Infarction in Malmo, 1935-54. Followup studies from hospital material. Acta Medica Scandinavica September 25, 1958, pp 81-97. Prognostic Value of Life Insurance Mortality Investigations. Journal AMA vol. 160, pp 736-741. 1956. Cancer in Connecticut 1935–51. Medico, Acturaial Mortality Charts, 1953. Griswold, M. H., Cutler, S. J., Survival of Patients with Uterine Cancer, Ederer, F., Greenberg, R. A. Guiss, L. W Connecticut, 1935-54. Journal of National Cancer Institute 24, No. 3, March 1960. A 5-Year Followup of Roentgenographically Detected Lung Cancer Suspects. Cancer, January-February 1960, pp. 82-90. |